Business
BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results
LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 (“Q4 2025”). "Our fourth quarter results reflects meaningful structural progress in margins, profitability, and balance sheet strength as our operational improvements are beginning to take hold,” said Pedro Malha, President and CEO of Bea
About this update from Skinhealth Systems Inc.
[{"type":"image","alt":"The Beauty Health Company","displaySize":"","headline":null,"caption":"The Beauty Health Company","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":32,"url":"https://media.zenfs.com/en/globenewswire.com/2b9d1aba359052a93b8ea97748b2b4fa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PacPRoO6jxO10se0Fvn7cQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQ1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/2b9d1aba359052a93b8ea97748b2b4fa","width":300,"height":32}},"lazy":false},{"type":"text","content":"LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 (“Q4 2025”).","length":284,"tagName":"p"},{"type":"text","content":""Our fourth quarter results reflects meaningful structural progress in margins, profitability, and balance sheet strength as our operational improvements are beginning to take hold,” said Pedro Malha, President and CEO of BeautyHealth.","length":240,"tagName":"p"},{"type":"text","content":"“BeautyHealth enters 2026 with a strong foundation — a globally recognized brand, one of the largest installed bases in aesthetics, and a strong recurring consumables model. Our focus now is to unlock the full economic potential of our platform by strengthening commercial execution, expanding utilization, improving provider economics, and investing in clinically meaningful innovation.”","length":388,"tagName":"p"},{"type":"text","content":"Key Operational and Business Metrics","length":36,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"colspan":"7","style":"text-align:center;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"Three Months Ended December 31,","length":31,"tagName":"p","attribs":{}}]},{"style":"vertical-align:bottom;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"colspan":"7","style":"text-align:center;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"Year Ended December 31,","length":23,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"te...